These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17289470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 4. 'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides.
    Kaushansky N, Kerlero de Rosbo N, Zilkha-Falb R, Yosef-Hemo R, Cohen L, Ben-Nun A.
    PLoS One; 2011 Jan 15; 6(11):e27860. PubMed ID: 22140475
    [Abstract] [Full Text] [Related]

  • 5. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H.
    J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903
    [Abstract] [Full Text] [Related]

  • 6. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin.
    Anderton SM, Wraith DC.
    Eur J Immunol; 1998 Apr 15; 28(4):1251-61. PubMed ID: 9565365
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A.
    Eur J Immunol; 1995 Apr 15; 25(4):985-93. PubMed ID: 7737302
    [Abstract] [Full Text] [Related]

  • 9. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
    Wegmann KW, Archie Bouwer HG, Whitham RH, Hinrichs DJ.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):46-52. PubMed ID: 24997489
    [Abstract] [Full Text] [Related]

  • 10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 15; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
    Karpus WJ, Kennedy KJ, Smith WS, Miller SD.
    J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901
    [Abstract] [Full Text] [Related]

  • 13. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, Squinto SP, Matis LA, Mueller JP.
    J Clin Invest; 1996 Oct 01; 98(7):1602-12. PubMed ID: 8833909
    [Abstract] [Full Text] [Related]

  • 14. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I, Kerlero de Rosbo N, Ben-Nun A.
    Eur J Immunol; 1995 Jul 01; 25(7):1951-9. PubMed ID: 7621871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ, Kennedy MK, Miller SD.
    J Immunol; 1992 May 01; 148(9):2748-55. PubMed ID: 1374098
    [Abstract] [Full Text] [Related]

  • 17. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas SS, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L.
    Exp Neurol; 2015 May 01; 267():254-67. PubMed ID: 25447934
    [Abstract] [Full Text] [Related]

  • 18. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
    Zhong MC, Kerlero de Rosbo N, Ben-Nun A.
    J Clin Invest; 2002 Jul 01; 110(1):81-90. PubMed ID: 12093891
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G, Rodi M, Kalbacher H, Chatzantoni K, Karagiannis F, Synodinos L, Plotas P, Papalois A, Dimisianos N, Papathanasopoulos P, Gatos D, Tselios T, Apostolopoulos V, Mouzaki A, Matsoukas J.
    Eur J Med Chem; 2015 Aug 28; 101():13-23. PubMed ID: 26112377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.